- Home
- DIT vs STRO Comparison
DIT vs STRO Comparison
Compare DIT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- STRO
- Stock Information
- Founded
- DIT 1981
- STRO 2003
- Country
- DIT United States
- STRO United States
- Employees
- DIT N/A
- STRO N/A
- Industry
- DIT Food Distributors
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DIT Consumer Discretionary
- STRO Health Care
- Exchange
- DIT Nasdaq
- STRO Nasdaq
- Market Cap
- DIT 70.4M
- STRO 74.3M
- IPO Year
- DIT 1995
- STRO 2018
- Fundamental
- Price
- DIT $116.90
- STRO $0.90
- Analyst Decision
- DIT
- STRO Hold
- Analyst Count
- DIT 0
- STRO 7
- Target Price
- DIT N/A
- STRO $1.97
- AVG Volume (30 Days)
- DIT 401.0
- STRO 523.1K
- Earning Date
- DIT 11-07-2025
- STRO 11-12-2025
- Dividend Yield
- DIT 0.86%
- STRO N/A
- EPS Growth
- DIT N/A
- STRO N/A
- EPS
- DIT 2.14
- STRO N/A
- Revenue
- DIT $2,251,684,195.00
- STRO $104,473,000.00
- Revenue This Year
- DIT N/A
- STRO $65.48
- Revenue Next Year
- DIT N/A
- STRO N/A
- P/E Ratio
- DIT $52.04
- STRO N/A
- Revenue Growth
- DIT 7.64
- STRO N/A
- 52 Week Low
- DIT $94.92
- STRO $0.52
- 52 Week High
- DIT $163.75
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- DIT 52.76
- STRO 50.46
- Support Level
- DIT $117.50
- STRO $0.83
- Resistance Level
- DIT $121.00
- STRO $1.01
- Average True Range (ATR)
- DIT 3.32
- STRO 0.09
- MACD
- DIT -0.37
- STRO -0.01
- Stochastic Oscillator
- DIT 58.33
- STRO 20.80
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.